Dr. Karel Diaz Reyes, MD

Dr. Diaz Reyes practices at Coral West Community Hospital in Miami, Florida, part of Keralty Hospital.

Dr. Diaz Reyes' NPI, 1669853537, was assigned on June 16, 2015. Dr. Diaz Reyes holds Florida license ME136891.

Dr. Diaz Reyes' primary practice is Coral West Community Hospital, at 2500 Sw 75th Ave, Miami, FL 33155 in Miami-Dade County. The practice phone is (305) 263-9270.

Dr. Diaz Reyes' primary practice is Coral West Community Hospital in Miami, Florida, part of Keralty Hospital. Dr. Diaz Reyes is also affiliated with HCA Florida Kendall Hospital. The medical group on file is First Docs. Dmand AI also links Dr. Diaz Reyes to 6 more hospitals, 5 skilled nursing facilities, 4 medical groups, 2 home health agencies, 2 hospices, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Diaz Reyes practices, 19 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Diaz Reyes' primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Diaz Reyes is licensed in Florida.

CMS data shows 5,865 Medicare services from Dr. Diaz Reyes across 10 procedure codes in 2024, for 522 Medicare patients. Medicare paid $468,658 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 522 Medicare patients who saw Dr. Diaz Reyes in 2024. The largest group is 85 and over, with 177 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 75% are also on Medicaid. Their average risk score is 3.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Diaz Reyes' median patient age at 76, with 56% women.

In 2024, Dr. Diaz Reyes wrote 4,702 Medicare Part D claims for 295 patients. 81% of them were for generic drugs. CMS names the drug for 4,003 of them, across 94 drugs with 11 or more claims each, at $271,920 in total drug cost. In 2023, CMS named 1,827 claims across 67 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Diaz Reyes for performance year 2024, reported individually. Dr. Diaz Reyes accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Diaz Reyes as offering telehealth.

CMS Open Payments shows 65 general payments to Dr. Diaz Reyes from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Sunovion Pharmaceuticals Inc. paid the most, $853.